Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-03-21 5:40 pm Sale | 13G | Olema Pharmaceuticals, Inc. OLMA | Kynam Capital Management LP | 2,025,234 5% | -38,398,598 (-94.99%) | View |
| 2023-02-14 3:45 pm Sale | 13G | Olema Pharmaceuticals, Inc. OLMA | Fairmount Funds Management LLC | 0 0% | -2,107,873 (Position Closed) | View |
| 2023-02-14 3:08 pm Sale | 13G | Olema Pharmaceuticals, Inc. OLMA | Cormorant Asset Management LP | 2,082,000 5.15% | -87,871 (-4.05%) | View |
| 2023-02-10 1:18 pm Purchase | 13G | Olema Pharmaceuticals, Inc. OLMA | Kynam Capital Management LP | 40,423,832 5% | 40,423,832 (New Position) | View |
| 2023-02-10 11:26 am Purchase | 13G | Olema Pharmaceuticals, Inc. OLMA | JANUS HENDERSON GROUP PLC JHG | 3,057,306 7.6% | 61,866 (+2.07%) | View |
| 2023-02-09 11:27 am Sale | 13G | Olema Pharmaceuticals, Inc. OLMA | VANGUARD GROUP INC | 1,475,350 3.65% | -673,703 (-31.35%) | View |
| 2023-02-06 2:56 pm Sale | 13G | Olema Pharmaceuticals, Inc. OLMA | WELLINGTON MANAGEMENT GROUP LLP | 0 0% | -2,019,109 (Position Closed) | View |
| 2022-11-14 4:43 pm Unchanged | 13G | Olema Pharmaceuticals, Inc. OLMA | RA CAPITAL MANAGEMENT L.P. | 0 0% | 0 (Unchanged) | View |
| 2022-07-08 4:57 pm Sale | 13G | Olema Pharmaceuticals, Inc. OLMA | BlackRock Inc. BLK | 1,305,504 3.2% | -992,660 (-43.19%) | View |
| 2022-05-16 4:30 pm Sale | 13G | Olema Pharmaceuticals, Inc. OLMA | RA CAPITAL MANAGEMENT L.P. | 0 0% | -2,150,404 (Position Closed) | View |
| 2022-02-14 4:11 pm Unchanged | 13G | Olema Pharmaceuticals, Inc. OLMA | RA CAPITAL MANAGEMENT L.P. | 2,150,404 5.3% | 0 (Unchanged) | View |
| 2022-02-14 3:01 pm Sale | 13G | Olema Pharmaceuticals, Inc. OLMA | Cormorant Asset Management LP | 2,169,871 5.39% | -1,025,673 (-32.10%) | View |
| 2022-02-11 1:26 pm Purchase | 13G | Olema Pharmaceuticals, Inc. OLMA | Fairmount Funds Management LLC | 2,107,873 5.2% | 2,107,873 (New Position) | View |
| 2022-02-10 4:49 pm Sale | 13G | Olema Pharmaceuticals, Inc. OLMA | JANUS HENDERSON GROUP PLC JHG | 2,995,440 7.4% | -643,398 (-17.68%) | View |
| 2022-02-10 08:28 am Purchase | 13G | Olema Pharmaceuticals, Inc. OLMA | VANGUARD GROUP INC | 2,149,053 5.33% | 2,149,053 (New Position) | View |
| 2022-02-04 4:12 pm Purchase | 13G | Olema Pharmaceuticals, Inc. OLMA | BlackRock Inc. BLK | 2,298,164 5.7% | 2,298,164 (New Position) | View |
| 2022-02-04 09:21 am Sale | 13G | Olema Pharmaceuticals, Inc. OLMA | WELLINGTON MANAGEMENT GROUP LLP | 2,019,109 5.01% | -50,206 (-2.43%) | View |
| 2021-12-02 5:05 pm Purchase | 13D | Olema Pharmaceuticals, Inc. OLMA | BIOTECHNOLOGY VALUE FUND L P | 7,411,503 18.4% | 750,000 (+11.26%) | View |
| 2021-02-16 4:39 pm Purchase | 13G | Olema Pharmaceuticals, Inc. OLMA | RA CAPITAL MANAGEMENT L.P. | 2,150,404 5.4% | 2,150,404 (New Position) | View |
| 2021-02-16 3:24 pm Sale | 13G | Olema Pharmaceuticals, Inc. OLMA | Cormorant Asset Management LP | 3,195,544 7.96% | -75,000 (-2.29%) | View |